Evotec (ETR:EVT) Hits New 52-Week Low at $12.76

Evotec SE (ETR:EVTGet Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as €12.76 ($13.87) and last traded at €13.10 ($14.24), with a volume of 663480 shares trading hands. The stock had previously closed at €13.04 ($14.17).

Evotec Trading Up 0.5 %

The firm’s 50-day moving average price is €15.10 and its 200-day moving average price is €17.67. The company has a quick ratio of 2.97, a current ratio of 2.16 and a debt-to-equity ratio of 51.61. The company has a market cap of $2.32 billion, a P/E ratio of -24.59, a price-to-earnings-growth ratio of 0.98 and a beta of 1.09.

About Evotec

(Get Free Report)

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health.

Further Reading

Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.